21 CFR 522.784

§ 522.784 Doxylamine.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 522.784, § 522.784 Doxylamine, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87426
Permanent ID: ys:prov:87426@1
SHA-256: d666e8fb2277fd93e8cd65acf8589c2148a8c83638c913f105b5648ecc799f85

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each milliliter contains 11.36 milligrams (mg) of doxylamine succinate. (b) Sponsor. See No. 000061 in § 510.600(c) of this chapter. (c) Conditions of use—(1) Amount—(i) Horses: Administer 25 mg per hundred pounds of body weight by intramuscular, subcutaneous, or slow intravenous injection. (ii) Dogs and cats: Administer 0.5 to 1 mg per pound of body weight by intramuscular or subcutaneous injection. Doses may be repeated at 8 to 12 hours, if necessary, to produce desired effect. (2) Indications for use. For use in conditions in which antihistaminic therapy may be expected to alleviate some signs of disease in horses, dogs, and cats. (3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.